Qiagen Stock
Qiagen N.V.
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- Netherlands
- CEO
- Jon Pratt
- Employees
- 5,500
- Market cap
- $9.5 B
- IPO
- 28/06/1996
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. Founded in 1984, the company is headquartered in Venlo, Netherlands, and operates within the Healthcare sector. With approximately 5,500 employees, Qiagen N.V. serves the Medical - Diagnostics &…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Qiagen stock: price history
1D
-0.1%
1W
+1.7%
1M
+7.5%
6M
+11.9%
YTD
-2.6%
1Y
-4.2%
2Y
+9.3%
5Y
-11.3%
10Y
+70.0%
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~1% weaker price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Qiagen
Analyst assessment of Qiagen
PRICE TARGET LOW
US$38.60
CONSENSUS
US$43.01
MEDIAN
US$43.00
PRICE TARGET HIGH
US$48.00
0
STRONG BUY
14
BUY
16
HOLD
0
SELL
0
STRONG SELL
30
TOTAL · Hold
As of: 14/10/2026
Qiagen stock metrics
P/E
23.66
P/B
2.83
EV/EBITDA
14.76
RETURN ON EQUITY
3.1%
NET MARGIN
19.3%
DEBT/EQUITY
0.49
DIVIDEND YIELD
5.7%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.4%
FLOAT SHARES
204,832,780
AVG. DAILY VOLUME (30D)
2,018,878
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -0.1%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Qiagen stock
What does Qiagen do?
Qiagen N.V. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in Netherlands.
The CEO is Jon Pratt, the company employs around 5,500 people.
The IPO was on 28/06/1996; the stock trades on NYSE under the ticker QGEN.
What do analysts say about Qiagen stock?
30 analysts rate the stock, the consensus is Hold (as of 14/10/2026).
The average price target is US$43.01, ranging from US$38.60 to US$48.00, with a median of US$43.00.
This is an external assessment, not a statement by Market Jury.
When does Qiagen report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly -1% stronger than usual.
Does Qiagen pay a dividend?
Yes. The last dividend was US$0.35 per share, ex-date 07/07/2026, paid on 14/07/2026.
The dividend yield is 5.7% (as of 30/06/2026).
Which stocks are comparable to Qiagen?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get Qiagen stock analyzed?
Clicking "Analyze stock" lets five strategies assess Qiagen against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.